• tooth doc
    Where does everyone see AFFY headed? How risky is this stock
    2/29/12
    Reply (16)
    • lfpdinc: might want to brace yourself for some decay in pps
      2/29/12
    • tooth doc: can you expand a bit...thanks
      2/29/12
    • bigfoot: My long term target for AFFY is 30, assuming the FDA approves peginesatide next month, which is expected (panel was 15-1-1 in favor.)
      2/29/12
    • tooth doc: why decay in pps
      2/29/12
    • tooth doc: if the panel was 15-1 in favor, why the laggardness. sorry, dont know much about this stock
      2/29/12
    • Windsun33: I think 30 is a bit high, considering that Amgen has over half the market locked up for a couple years. Might be good short term on hype
      2/29/12
    • bigfoot: That was just an advisory panel, FDA doesn't meet on AFFY until March 27th. The wheels of government turn slow.
      2/29/12
    • bigfoot: If you're only looking at short term, AFFY is probably too speculative for you. It may be overbought on anticipation of FDA decision.
      2/29/12
    • tooth doc: so youre long in the short term but not sure if youre holding long term
      2/29/12
    • bigfoot: No, I'm definitely long term, I started buying it 3-4 years ago.
      2/29/12
    • tooth doc: might be worth picking up a few shares. thanks
      2/29/12
    • bigfoot: I could have gotten a 20% profit in a month, but I'm looking for a 400% return by 2015.
      2/29/12
    • lfpdinc: Jan 1 pps=6.50, its 10.33 now.....its already made its move prior to FDA hearing. the price will flux somewhat until the hearing
      2/29/12
    • Windsun33: Earnings report on Mar 8, not sure I would buy before then
      2/29/12
    • bigfoot: good point. Not much to say in earning report, just got $5M progress payment.
      2/29/12
    • bigfoot: Until peginesatide is on the market, progress payments are AFFY's main source of revenue.
      2/29/12